TOFI Visceral Fat Analyzer Cardiometabolic Risk

Anatomical cross-section & ectopic lipid infiltration simulator ("Thin Outside, Fat Inside")

2D Abdominal Cross-Section

Subcut. Fat
Muscle Wall
Visceral Fat
TOFI Pathophysiology: Even with normal external body appearance (low subcutaneous skinfold layer), deep intra-abdominal visceral fat wraps around vital abdominal organs, releasing pro-inflammatory cytokines into portal circulation.

Biomarker Sensitivity Controls

Height 175 cm
Weight 68 kg
Waist Circumference 86 cm
Subcutaneous Skinfold 12 mm
Visceral Fat Area (VFA) 135 cm²
Triglycerides 180 mg/dL
HDL Cholesterol 38 mg/dL
Fasting Blood Glucose 104 mg/dL

Cardiometabolic Phenotype

Metabolic Phenotype Classification
TOFI (Thin Outside, Fat Inside)
Body Mass Index (BMI)
22.2
Normal Mass
Waist-to-Height Ratio
0.49
Sub-threshold (<0.50)
Visceral Fat Status
Elevated Risk (>100 cm²)
High Organ Fat
Lipid Accumulation (LAP)
54.6
High Accumulation
Ectopic Organ Lipid Infiltration
MASLD (Fatty Liver) Risk High (72%)

Visceral adipocyte lipolysis releases free fatty acids directly into the portal vein (portal hypothesis), promoting hepatic lipid accumulation, steatohepatitis, and altered lipid export.